Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.17%348.81M | -0.57%165.12M | -13.85%349.42M | -17.23%166.07M | -21.41%405.61M | -24.45%200.64M | -29.02%516.14M | -13.67%265.59M | -7.88%727.17M | -15.35%307.62M |
| Operating income | -0.17%348.81M | -0.57%165.12M | -13.85%349.42M | -17.23%166.07M | -21.41%405.61M | -24.45%200.64M | -29.02%516.14M | -13.67%265.59M | -7.88%727.17M | -15.35%307.62M |
| Cost of sales | 4.84%-280.32M | 4.83%-139.08M | 13.41%-294.59M | 16.67%-146.14M | 14.38%-340.2M | 16.49%-175.37M | 25.81%-397.31M | 1.56%-210M | 5.98%-535.5M | 16.64%-213.32M |
| Operating expenses | 4.84%-280.32M | 4.83%-139.08M | 13.41%-294.59M | 16.67%-146.14M | 14.38%-340.2M | 16.49%-175.37M | 25.81%-397.31M | 1.56%-210M | 5.98%-535.5M | 16.64%-213.32M |
| Gross profit | 24.92%68.49M | 30.67%26.04M | -16.18%54.83M | -21.12%19.93M | -44.95%65.42M | -54.55%25.27M | -38.00%118.83M | -41.06%55.59M | -12.79%191.67M | -12.27%94.3M |
| Selling expenses | 16.80%-14.63M | 24.00%-7.66M | 8.71%-17.59M | 0.38%-10.08M | 12.80%-19.26M | 30.82%-10.12M | 7.64%-22.09M | -65.82%-14.63M | -243.08%-23.92M | -43.07%-8.82M |
| Administrative expenses | 0.07%-43.67M | 9.42%-19.99M | 12.20%-43.7M | 3.34%-22.07M | 15.03%-49.77M | 23.90%-22.83M | 1.92%-58.57M | 1.68%-30M | -5.82%-59.72M | -26.32%-30.52M |
| Research and development expenses | 12.25%-5.02M | 8.35%-2.48M | 5.60%-5.72M | ---2.71M | ---6.06M | ---- | ---- | ---- | ---- | ---- |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | --27.3M | --27.3M | ---- | ---- |
| Impairment and provision | 22.52%6.14M | -85.57%278K | -68.04%5.01M | 14,923.08%1.93M | 817.25%15.67M | ---13K | 92.38%-2.19M | ---- | -29.43%-28.69M | ---- |
| -Other impairment is provision | 22.52%6.14M | -85.57%278K | -68.04%5.01M | 14,923.08%1.93M | 817.25%15.67M | ---13K | 92.38%-2.19M | ---- | -29.43%-28.69M | ---- |
| Special items of operating profit | -27.45%1.76M | -10.19%3.84M | 151.20%2.42M | 162.65%4.28M | 13.41%-4.73M | -439.34%-6.83M | 5.62%-5.46M | -256.30%-1.27M | 17.10%-5.78M | 252.26%810K |
| Operating profit | 375.68%13.07M | 100.32%28K | -471.84%-4.74M | 39.95%-8.73M | -97.80%1.28M | -139.28%-14.53M | -21.39%57.83M | -33.68%36.99M | -42.19%73.56M | -10.87%55.77M |
| Financing income | -54.33%2.08M | -35.52%1.18M | -16.80%4.55M | -48.35%1.83M | 0.90%5.47M | 269.21%3.54M | 30.92%5.42M | -70.70%958K | 929.85%4.14M | 212.32%3.27M |
| Financing cost | 11.65%-1.6M | 8.86%-833K | 52.09%-1.81M | 55.44%-914K | 33.49%-3.78M | 34.87%-2.05M | 12.85%-5.68M | 0.47%-3.15M | 31.82%-6.52M | 41.00%-3.16M |
| Share of profits of associates | 48.53%-4.86M | 28.73%-3.67M | -0.31%-9.45M | -16.30%-5.15M | -29.88%-9.42M | -21.44%-4.42M | -13.48%-7.25M | 11.96%-3.64M | -162.02%-6.39M | -169.28%-4.14M |
| Share of profit from joint venture company | 12.76%-9.3M | 24.36%-4.46M | 9.09%-10.66M | 3.60%-5.89M | 10.10%-11.73M | 11.95%-6.11M | -193.78%-13.04M | -305.08%-6.94M | -141.96%-4.44M | -162.33%-1.71M |
| Earning before tax | 97.23%-613K | 58.88%-7.75M | -21.61%-22.11M | 20.06%-18.85M | -148.77%-18.18M | -197.36%-23.58M | -38.25%37.27M | -51.59%24.22M | -52.31%60.35M | -21.31%50.03M |
| Tax | -33.05%-12.64M | -18.54%-5.76M | 27.24%-9.5M | 24.09%-4.86M | 34.84%-13.05M | 43.90%-6.4M | -169.41%-20.03M | -3.32%-11.41M | 69.65%-7.44M | -25.29%-11.04M |
| After-tax profit from continuing operations | 58.08%-13.25M | 43.01%-13.51M | -1.20%-31.61M | 20.92%-23.71M | -281.19%-31.23M | -334.08%-29.98M | -67.43%17.24M | -67.15%12.81M | -48.14%52.92M | -28.81%38.98M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | 64.21%-4.54M | ---7.27M | ---12.67M | ---- | ---- | ---- |
| Special items of earning after tax | ---- | ---- | ---- | ---- | 64.21%-4.54M | ---7.27M | ---12.67M | ---- | ---- | ---- |
| Earning after tax | 58.08%-13.25M | 43.01%-13.51M | 11.64%-31.61M | 36.35%-23.71M | -883.68%-35.77M | -390.83%-37.25M | -91.38%4.56M | -67.15%12.81M | -48.14%52.92M | -28.81%38.98M |
| Minority profit | 30.15%-3.68M | 16.43%-2.89M | -98.94%-5.27M | 15.29%-3.46M | 2.21%-2.65M | -108.90%-4.08M | -121.67%-2.71M | -119.09%-1.95M | -54.50%12.5M | -37.58%10.24M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | -243.30%-28.58M | ---25.9M | --19.95M | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | 64.21%-4.54M | ---7.27M | ---12.67M | ---- | ---- | ---- |
| Profit attributable to shareholders | 63.66%-9.57M | 47.56%-10.62M | 20.48%-26.34M | 38.95%-20.25M | -555.36%-33.12M | -324.68%-33.17M | -82.01%7.27M | -48.65%14.76M | -45.80%40.42M | -25.06%28.75M |
| Basic earnings per share | 63.22%-0.0032 | 47.76%-0.0035 | 20.18%-0.0087 | 38.53%-0.0067 | -554.17%-0.0109 | -322.45%-0.0109 | -81.95%0.0024 | -48.42%0.0049 | -45.93%0.0133 | -24.60%0.0095 |
| Diluted earnings per share | 63.22%-0.0032 | 47.76%-0.0035 | 20.18%-0.0087 | 38.53%-0.0067 | -554.17%-0.0109 | -322.45%-0.0109 | -81.95%0.0024 | -48.42%0.0049 | -45.93%0.0133 | -24.60%0.0095 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.